Human chorionic gonadotropin is an immune modulator and can prevent autoimmune diabetes in NOD mice

L. Y. Khil, H. S. Jun, H. Kwon, J. K. Yoo, S. Kim, A. L. Notkins, J. W. Yoon

Research output: Contribution to journalArticle

26 Citations (Scopus)

Abstract

Aims/hypothesis: Expression of T helper (Th)1 cytokine mRNA in pregnant women is known to be inversely correlated with serum human chorionic gonadotropin (hCG). Type 1 diabetes is a Th1-mediated autoimmune disease, in which intervention at an early stage of the autoimmune process can prevent disease progression. We hypothesised that immune modulation by treating young NOD mice with hCG may prevent diabetes. Methods: Female NOD mice were treated with hCG or recombinant hCG from 3 to 15 weeks of age and the incidence of diabetes and development of insulitis was determined. CD4+ and CD8+ T cell populations, T cell proliferation, cytokine production and CD4+CD25+ regulatory T cells were examined and adoptive transfer experiments were performed. Results: Both purified and recombinant hCG prevented development of diabetes in NOD mice. hCG decreased the proportion and number of CD4+ and CD8+ T cells and inhibited T cell proliferative responses against beta cell antigens. hCG treatment suppressed IFN-γ production, but increased IL-10 and TGF-β production in splenocytes stimulated with anti-CD3 antibody. hCG treatment also suppressed TNF-α production in splenocytes stimulated with lipopolysaccharide. Furthermore, hCG treatment increased the CD4 +CD25+/CD4+ T cell ratio in spleen and pancreatic lymph nodes. Depletion of CD4+CD25+ T cells from splenocytes of hCG-treated NOD mice abolished their preventive effect on diabetes transfer. Conclusions/interpretation: We conclude that hCG has an immunomodulatory effect by downregulating effector cells, including Th1 cells, CD8+ T cells and macrophages, and increasing the CD4 +CD25+/CD4+ T cell ratio, thus preventing autoimmune diabetes in NOD mice.

Original languageEnglish (US)
Pages (from-to)2147-2155
Number of pages9
JournalDiabetologia
Volume50
Issue number10
DOIs
StatePublished - Oct 2007
Externally publishedYes

Fingerprint

Inbred NOD Mouse
Chorionic Gonadotropin
Type 1 Diabetes Mellitus
T-Lymphocytes
Cytokines
Th1 Cells
Adoptive Transfer
Regulatory T-Lymphocytes
Interleukin-10
Autoimmune Diseases
Lipopolysaccharides
Disease Progression
Pregnant Women
Anti-Idiotypic Antibodies
Therapeutics
Down-Regulation
Spleen
Lymph Nodes
Macrophages
Cell Proliferation

Keywords

  • Autoimmune disease
  • Cytokines
  • Human chorionic gonadotropin
  • Immune regulation
  • Insulitis
  • NOD mice
  • Regulatory T cells
  • T cells
  • Th1 immune response
  • Type 1 diabetes

ASJC Scopus subject areas

  • Internal Medicine
  • Endocrinology, Diabetes and Metabolism

Cite this

Khil, L. Y., Jun, H. S., Kwon, H., Yoo, J. K., Kim, S., Notkins, A. L., & Yoon, J. W. (2007). Human chorionic gonadotropin is an immune modulator and can prevent autoimmune diabetes in NOD mice. Diabetologia, 50(10), 2147-2155. https://doi.org/10.1007/s00125-007-0769-y

Human chorionic gonadotropin is an immune modulator and can prevent autoimmune diabetes in NOD mice. / Khil, L. Y.; Jun, H. S.; Kwon, H.; Yoo, J. K.; Kim, S.; Notkins, A. L.; Yoon, J. W.

In: Diabetologia, Vol. 50, No. 10, 10.2007, p. 2147-2155.

Research output: Contribution to journalArticle

Khil, LY, Jun, HS, Kwon, H, Yoo, JK, Kim, S, Notkins, AL & Yoon, JW 2007, 'Human chorionic gonadotropin is an immune modulator and can prevent autoimmune diabetes in NOD mice', Diabetologia, vol. 50, no. 10, pp. 2147-2155. https://doi.org/10.1007/s00125-007-0769-y
Khil, L. Y. ; Jun, H. S. ; Kwon, H. ; Yoo, J. K. ; Kim, S. ; Notkins, A. L. ; Yoon, J. W. / Human chorionic gonadotropin is an immune modulator and can prevent autoimmune diabetes in NOD mice. In: Diabetologia. 2007 ; Vol. 50, No. 10. pp. 2147-2155.
@article{b7b14259d8dd4d72bbdfcbb891bd3e25,
title = "Human chorionic gonadotropin is an immune modulator and can prevent autoimmune diabetes in NOD mice",
abstract = "Aims/hypothesis: Expression of T helper (Th)1 cytokine mRNA in pregnant women is known to be inversely correlated with serum human chorionic gonadotropin (hCG). Type 1 diabetes is a Th1-mediated autoimmune disease, in which intervention at an early stage of the autoimmune process can prevent disease progression. We hypothesised that immune modulation by treating young NOD mice with hCG may prevent diabetes. Methods: Female NOD mice were treated with hCG or recombinant hCG from 3 to 15 weeks of age and the incidence of diabetes and development of insulitis was determined. CD4+ and CD8+ T cell populations, T cell proliferation, cytokine production and CD4+CD25+ regulatory T cells were examined and adoptive transfer experiments were performed. Results: Both purified and recombinant hCG prevented development of diabetes in NOD mice. hCG decreased the proportion and number of CD4+ and CD8+ T cells and inhibited T cell proliferative responses against beta cell antigens. hCG treatment suppressed IFN-γ production, but increased IL-10 and TGF-β production in splenocytes stimulated with anti-CD3 antibody. hCG treatment also suppressed TNF-α production in splenocytes stimulated with lipopolysaccharide. Furthermore, hCG treatment increased the CD4 +CD25+/CD4+ T cell ratio in spleen and pancreatic lymph nodes. Depletion of CD4+CD25+ T cells from splenocytes of hCG-treated NOD mice abolished their preventive effect on diabetes transfer. Conclusions/interpretation: We conclude that hCG has an immunomodulatory effect by downregulating effector cells, including Th1 cells, CD8+ T cells and macrophages, and increasing the CD4 +CD25+/CD4+ T cell ratio, thus preventing autoimmune diabetes in NOD mice.",
keywords = "Autoimmune disease, Cytokines, Human chorionic gonadotropin, Immune regulation, Insulitis, NOD mice, Regulatory T cells, T cells, Th1 immune response, Type 1 diabetes",
author = "Khil, {L. Y.} and Jun, {H. S.} and H. Kwon and Yoo, {J. K.} and S. Kim and Notkins, {A. L.} and Yoon, {J. W.}",
year = "2007",
month = "10",
doi = "10.1007/s00125-007-0769-y",
language = "English (US)",
volume = "50",
pages = "2147--2155",
journal = "Diabetologia",
issn = "0012-186X",
publisher = "Springer Verlag",
number = "10",

}

TY - JOUR

T1 - Human chorionic gonadotropin is an immune modulator and can prevent autoimmune diabetes in NOD mice

AU - Khil, L. Y.

AU - Jun, H. S.

AU - Kwon, H.

AU - Yoo, J. K.

AU - Kim, S.

AU - Notkins, A. L.

AU - Yoon, J. W.

PY - 2007/10

Y1 - 2007/10

N2 - Aims/hypothesis: Expression of T helper (Th)1 cytokine mRNA in pregnant women is known to be inversely correlated with serum human chorionic gonadotropin (hCG). Type 1 diabetes is a Th1-mediated autoimmune disease, in which intervention at an early stage of the autoimmune process can prevent disease progression. We hypothesised that immune modulation by treating young NOD mice with hCG may prevent diabetes. Methods: Female NOD mice were treated with hCG or recombinant hCG from 3 to 15 weeks of age and the incidence of diabetes and development of insulitis was determined. CD4+ and CD8+ T cell populations, T cell proliferation, cytokine production and CD4+CD25+ regulatory T cells were examined and adoptive transfer experiments were performed. Results: Both purified and recombinant hCG prevented development of diabetes in NOD mice. hCG decreased the proportion and number of CD4+ and CD8+ T cells and inhibited T cell proliferative responses against beta cell antigens. hCG treatment suppressed IFN-γ production, but increased IL-10 and TGF-β production in splenocytes stimulated with anti-CD3 antibody. hCG treatment also suppressed TNF-α production in splenocytes stimulated with lipopolysaccharide. Furthermore, hCG treatment increased the CD4 +CD25+/CD4+ T cell ratio in spleen and pancreatic lymph nodes. Depletion of CD4+CD25+ T cells from splenocytes of hCG-treated NOD mice abolished their preventive effect on diabetes transfer. Conclusions/interpretation: We conclude that hCG has an immunomodulatory effect by downregulating effector cells, including Th1 cells, CD8+ T cells and macrophages, and increasing the CD4 +CD25+/CD4+ T cell ratio, thus preventing autoimmune diabetes in NOD mice.

AB - Aims/hypothesis: Expression of T helper (Th)1 cytokine mRNA in pregnant women is known to be inversely correlated with serum human chorionic gonadotropin (hCG). Type 1 diabetes is a Th1-mediated autoimmune disease, in which intervention at an early stage of the autoimmune process can prevent disease progression. We hypothesised that immune modulation by treating young NOD mice with hCG may prevent diabetes. Methods: Female NOD mice were treated with hCG or recombinant hCG from 3 to 15 weeks of age and the incidence of diabetes and development of insulitis was determined. CD4+ and CD8+ T cell populations, T cell proliferation, cytokine production and CD4+CD25+ regulatory T cells were examined and adoptive transfer experiments were performed. Results: Both purified and recombinant hCG prevented development of diabetes in NOD mice. hCG decreased the proportion and number of CD4+ and CD8+ T cells and inhibited T cell proliferative responses against beta cell antigens. hCG treatment suppressed IFN-γ production, but increased IL-10 and TGF-β production in splenocytes stimulated with anti-CD3 antibody. hCG treatment also suppressed TNF-α production in splenocytes stimulated with lipopolysaccharide. Furthermore, hCG treatment increased the CD4 +CD25+/CD4+ T cell ratio in spleen and pancreatic lymph nodes. Depletion of CD4+CD25+ T cells from splenocytes of hCG-treated NOD mice abolished their preventive effect on diabetes transfer. Conclusions/interpretation: We conclude that hCG has an immunomodulatory effect by downregulating effector cells, including Th1 cells, CD8+ T cells and macrophages, and increasing the CD4 +CD25+/CD4+ T cell ratio, thus preventing autoimmune diabetes in NOD mice.

KW - Autoimmune disease

KW - Cytokines

KW - Human chorionic gonadotropin

KW - Immune regulation

KW - Insulitis

KW - NOD mice

KW - Regulatory T cells

KW - T cells

KW - Th1 immune response

KW - Type 1 diabetes

UR - http://www.scopus.com/inward/record.url?scp=34548501744&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=34548501744&partnerID=8YFLogxK

U2 - 10.1007/s00125-007-0769-y

DO - 10.1007/s00125-007-0769-y

M3 - Article

VL - 50

SP - 2147

EP - 2155

JO - Diabetologia

JF - Diabetologia

SN - 0012-186X

IS - 10

ER -